NU
Holdco Nuvo Group D.G Ltd. Ordinary Shares
NUVO · NASDAQ
$0.17 N/A (+$0.17)
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
-
N/A PEG N/A
P/E N/A
P/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Int. coverage N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
50 /100
Moderate Beta -0.41x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NUVO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Maurice Powell Jr.
Employees
-
Headquarters
Tel Aviv